By Stephanie N. Rotondo
Seattle, June 30 – IntelGenx Technologies Corp. priced and amended a previously announced bought-deal agreement to sell 8% convertible unsecured subordinated debentures due June 30, 2020 in a prospectus filed with the Securities and Exchange Commission on Friday.
The minimum deal size was reduced to C$5 million from C$7 million. The maximum amount was steady at C$10 million.
The offering is being led by Desjardins Securities Inc.
The C$1,000-par debentures will be sold in the provinces of British Columbia, Alberta, Manitoba, Ontario and Quebec.
Conversions will be settled in common stock. The initial conversion price is C$1.35, an initial conversion premium of 8% and equal to a conversion rate of 740 shares per each C$1,000 of notes.
The convertibles will be redeemable after June 30, 2018 and through June 30, 2019, only if the company’s stock price hits a 125% price hurdle. After June 30, 2019, the paper can be redeemed at any time.
Upon a change of control, the company will be required to make a repurchase offer for the notes at 101% of par plus accrued interest.
Proceeds will be used for capital expansion, clinical studies, product development and general working capital requirements.
IntelGenx is a Quebec-based drug delivery company.
Issuer: | IntelGenx Technologies Corp.
|
Securities: | Convertible unsecured subordinated debentures
|
Amount: | Minimum: C$5 million
|
| Maximum: C$10 million
|
Maturity: | June 30, 2020
|
Bookrunner: | Desjardins Securities Inc.
|
Coupon: | 8%
|
Price: | Par of C$1,000
|
Yield: | 8%
|
Call options: | On or after June 30, 2019 at par plus accrued interest
|
Provisional call: | From June 30, 2018 if the stock hits a 125% price hurdle
|
Initial conversion price: | C$1.35
|
Initial conversion premium: | 8%
|
Initial conversion rate: | 740 shares
|
Pricing date: | June 30
|
Settlement date: | July 12
|
Stock symbol: | TSX: IGX
|
Stock price: | C$1.25 as of June 29 close
|
Market capitalization: | C$90.67 million
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.